AI_PREMie: addressing the global health challenge of preeclampsia
AI_PREMie will arm clinical care providers with an affordable risk stratification tool. We aim to empower clinicians by developing a powerful risk stratification tool, that will help in their diagnosis and care management of women affected by preeclampsia.
Preeclampsia is a serious pregnancy complication typically characterised by the development of high blood pressure and protein in the urine, and it affects one in every 10 pregnancies. Every year it claims the lives of 50,000 mothers and 500,000 babies, making it one of the world’s deadliest pregnancy complications.
Diagnosis remains a serious challenge, and pre-term delivery of the baby is the only cure and the safest option for the mother. Therefore, an additional 5 million babies are born prematurely each year – sometimes very prematurely – which poses its own risks for the survival chances and long-term health of the child. Accurate risk stratification, where patients are assigned health risk statuses to help inform care, is urgently required to reduce these enormous competing risks.
Professor Maguire and her team have drawn upon cutting-edge biomedical, clinical and machine-learning knowhow to develop a prototype risk stratification tool, AI_PREMie, for preeclampsia. Their solution will be able to assist clinical decision making in real-time, hopefully enabling more accurate diagnosis and personalised treatment that will save lives.
AI_PREMie is currently being piloted in the three main maternity hospitals in Ireland, capturing 50% of all Irish births (National Maternity Hospital, Rotunda Hospital & Coombe Women & Infants University Hospital).
AI PREMie is a Science Foundation Ireland (SFI) funded research project, carried out in collaboration with Microsoft & SAS Software.